Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine

@article{Weiner2010AdjunctiveRF,
  title={Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine},
  author={Elaine Weiner and Robert R. Conley and M. Patricia Ball and Stephanie Feldman and James M Gold and Deanna L Kelly and Ikwunga Wonodi and Robert P. McMahon and Robert Williams Buchanan},
  journal={Neuropsychopharmacology},
  year={2010},
  volume={35},
  pages={2274-2283}
}
  • Elaine Weiner, Robert R. Conley, +6 authors Robert Williams Buchanan
  • Published in Neuropsychopharmacology 2010
  • Psychology, Medicine
  • The large numbers of partial clozapine responders represent a major therapeutic challenge. Unfortunately, there are no clear data to support how best to treat these patients. This study examines the efficacy and safety of adjunctive risperidone in a well-defined treatment-resistant population optimally treated with clozapine. A total of 69 inpatients and outpatients with DSM-IV schizophrenia or schizoaffective disorder entered a 16-week double-blind, placebo-controlled, randomized clinical… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 18 CITATIONS

    Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.

    VIEW 4 EXCERPTS
    CITES METHODS & BACKGROUND
    HIGHLY INFLUENCED

    Augmentation strategies for clozapine refractory schizophrenia: A systematic review and meta-analysis

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 54 REFERENCES

    The Brief Psychiatric Rating Scale

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    Structural Clinical Interview for DSM-IV Axis Disorders (SCID-IV)

    • MB First, RL Spitzer, M Gibbon, J Williams
    • Biometrics Research Department,
    • 1997
    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    Intention-to-treat. What is the question?

    VIEW 2 EXCERPTS

    Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.

    VIEW 2 EXCERPTS